MANNKIND CORP Uncategorized Contracts & Agreements
41 Contracts & Agreements
- Research Agreement, dated September 3, 2018 by and between MannKind and United Therapeutics Corporation (Filed With SEC on November 7, 2024)
- Offer Letter, dated March 25, 2024, between MannKind Corporation and Chris Prentiss (Filed With SEC on March 26, 2024)
- Offer Letter, dated May 16, 2023, by and between MannKind Corporation and Sanjay Singh (Filed With SEC on February 27, 2024)
- Offer Letter, dated September 19, 2022, by and between MannKind Corporation and Burkhard Blank (Filed With SEC on February 27, 2024)
- Offer Letter, dated March 21, 2023, by and between MannKind Corporation and Lauren M. Sabella (Filed With SEC on March 27, 2023)
- Offer Letter, dated August 11, 2003, by and between MannKind and Joseph Kocinsky (Filed With SEC on February 25, 2021)
- Offer Letter, dated May 7, 2020 by and between MannKind and Alejandro Galindo (Filed With SEC on February 25, 2021)
- Research Agreement, dated September 3, 2018 by and between MannKind and United Therapeutics Corporation (Filed With SEC on November 1, 2018)
- Offer Letter dated February 2, 2018, by and between MannKind and David Kendall (Filed With SEC on February 27, 2018)
- Offer Letter dated June 28, 2017, by and between MannKind and Patrick McCauley (Filed With SEC on February 27, 2018)
- Offer Letter dated February 17, 2017, by and between MannKind and Courtney Barton (Filed With SEC on February 27, 2018)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 4, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 4, 2011)
- OMNI CAPITAL CORPORATION 119 West 72nd Street Suite 283 33 West Main Street POB 390New York, NY 10023 Oyster Bay, NY 11771 Mr. Matthew J. Pfeffer August 10, 2010Chief Financial... (Filed With SEC on August 11, 2010)
- 7,400,000 Shares (Filed With SEC on August 10, 2009)
- Current assets (Filed With SEC on May 4, 2009)
- Current assets (Filed With SEC on May 4, 2009)
- Current assets (Filed With SEC on August 9, 2007)
- MANNKIND CORPORATION (Filed With SEC on December 8, 2006)
- MANNKIND CORPORATION (Filed With SEC on December 8, 2006)
- Current assets (Filed With SEC on November 2, 2006)
- Current assets (Filed With SEC on August 3, 2006)
- Pro forma (Filed With SEC on September 3, 2004)
- Consent of Deloitte & Touche LLP (Filed With SEC on July 27, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
- Technosphere Insulin approximation (Filed With SEC on April 30, 2004)
